Viewing Study NCT06408376



Ignite Creation Date: 2024-05-11 @ 8:31 AM
Last Modification Date: 2024-10-26 @ 3:29 PM
Study NCT ID: NCT06408376
Status: RECRUITING
Last Update Posted: 2024-05-10
First Post: 2024-01-22

Brief Title: Physiological Umbilical Cord Clamping in Patients With Congenital Diaphragmatic Hernia Clinical Trial
Sponsor: Hospital JP Garrahan
Organization: Hospital JP Garrahan

Study Overview

Official Title: Physiological Umbilical Cord Clamping in Patients With Congenital Diaphragmatic Hernia Clinical Trial
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Congenital diaphragmatic hernia CDH is a malformation that affects 1 in every 3000 newborns The diaphragm does not complete its closure during embryogenesis which allows the abdominal organs to herniate into the thoracic cavity altering lung development The lungs of patients with CDH are small with a decreased surface area for gas exchange and developmental impair of the pulmonary vasculature resulting in respiratory failure and pulmonary hypertension shortly after birth When clamping the umbilical cord a large part of the preload is abruptly excluded generating an increase in vascular resistance which in turn increase the afterload resulting in a decrease in cardiac output The output is restored by decreasing vascular resistance in pulmonary circuit after lung aeration upon receiving the preload of the right atrium increasing pulmonary flow and thus sustaining the preload of the left ventricle If pulmonary aeration occurs before clamping the umbilical cord the pulmonary blood flow increases before placenta flow is lost thus avoiding a decrease in cardiac output This modality has been called physiological base cord clamping PFC The hypothesis is that PFC once ventilation has been established could prevent hypoxia and improve cardiac output in newborns with CDH and secondarily improve their hemodynamic parameters stabilizing gas exchange and pulmonary hypertension during the first 24 hours of birth
Detailed Description: Type of study Randomized clinical trial
Primary objective To establish the effectiveness of PFC in reducing hypoxia and improving cardiac output compared to immediate postintubation clamping in newborns with CDH To establish the safety and feasibility of PFC after pulmonary recruitment achieved post intubation
Secondary objectives describe the evolution of patients with CDH 24 hours after birth under pre-established conditions Relate prenatal indices to the subsequent evolution of these patients Describe maternal evolution and postpartum complications
Population Patients who attend the Fetal Diagnosis and Treatment program of Garrahan Childrens Hospital and undergo prenatal diagnosis of CDH are possible candidates The study will be carried out in the Neonatal Intensive Care Unit of said hospital
Scope of the study Garrahan Childrens Hospital is a level 3 B pediatric hospital and national referral center located in Autonomous City of Buenos Aires Argentina Center that receives neonates with CDH referred from all over the country as well as from other countries in the region and carries out the relevant training for equal reception
Block randomization will be carried out on the same day 2 hours before entering the delivery room
Intervention Immediately after birth the newborn will be placed on a mobile table made to received these patients in the delivery room at the level of the mothers womb leaving the umbilical cord intact intubated and gently ventilated positive inspiration pressure PIM 1525 - positive end expiratory pressure PEEP4 - fraction of inspired oxygen inspired oxygen fraction FiO2 50 until saturation 85 and heart rate HR 100 or 10 timed minutes pass whichever occurs first the umbilical cord will be clamped and continued with the usual reception steps in accordance with the units CDH reception protocol
Sample size To calculate the sample size a prevalence of hemodynamic alterations of 60 was considered in the first 24 hours of life of patients with CDH following unit statistics and the aforementioned bibliography The estimated sample size with a relative reduction of 50 reduction from 60 to 30 of hemodynamic alterations - Power of 80 - Two-tailed test - alpha 5 40 patients required in each branch

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
6721 OTHER PRIISA BA None